Comparisons of Intravenous Ceftriaxone With Intravenous Moxifloxacin in ERCP

NCT02098486 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

86

Enrollment

OTHER

Sponsor class

Conditions

Cholangitis

Interventions

DRUG: Moxifloxacin
DRUG: ceftriaxone

Sponsor

Kangbuk Samsung Hospital